Published in Clin Exp Immunol on January 01, 2013
Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater (2013) 1.15
Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res Ther (2016) 0.88
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med (2015) 0.88
Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling. Clin Proteomics (2014) 0.87
Telocytes in minor salivary glands of primary Sjögren's syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis. J Cell Mol Med (2015) 0.87
Clinicopathological correlations of podoplanin (gp38) expression in rheumatoid synovium and its potential contribution to fibroblast platelet crosstalk. PLoS One (2014) 0.86
Modulation of TNF-induced macrophage polarization by synovial fibroblasts. J Immunol (2014) 0.86
Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? Arthritis Res Ther (2015) 0.83
Stretching Impacts Inflammation Resolution in Connective Tissue. J Cell Physiol (2015) 0.82
Characterization of autoimmune inflammation induced prostate stem cell expansion. Prostate (2015) 0.81
Immune resolution mechanisms in inflammatory arthritis. Nat Rev Rheumatol (2017) 0.78
The Role of the Fibroblast in Inflammatory Upper Airway Conditions. Am J Pathol (2015) 0.77
Contribution of Human Fibroblasts and Endothelial Cells to the Hallmarks of Inflammation as Determined by Proteome Profiling. Mol Cell Proteomics (2016) 0.76
The role of stromal cells in inflammatory bone loss. Clin Exp Immunol (2017) 0.75
Proliferation of Interstitial Cells in the Cyclophosphamide-Induced Cystitis and the Preventive Effect of Imatinib. Biomed Res Int (2017) 0.75
NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis. Exp Mol Med (2017) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature (2007) 15.20
Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A (2002) 6.98
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science (2010) 4.56
Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol (2008) 4.05
Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol (2010) 3.69
Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol (1996) 3.59
A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One (2010) 3.14
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol (2001) 3.08
Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One (2009) 2.87
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum (2000) 2.61
Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med (2009) 2.55
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum (2009) 2.38
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med (1991) 2.32
Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol (2011) 2.26
Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol (2000) 2.16
Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med (2008) 2.15
Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res (1996) 2.12
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol (2005) 1.96
Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther (2010) 1.95
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest (2010) 1.90
A stromal address code defined by fibroblasts. Trends Immunol (2005) 1.90
Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol (1999) 1.88
Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica (2008) 1.87
Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol (1999) 1.87
Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol (1994) 1.83
Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol (2001) 1.80
Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol (2000) 1.79
Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol (2009) 1.76
Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum (2001) 1.59
Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum (2003) 1.56
Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Haemost (2003) 1.55
A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol (2005) 1.41
Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J Immunol (2011) 1.39
Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum (2007) 1.38
A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum (2005) 1.36
Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum (2005) 1.27
Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis. Arthritis Res Ther (2010) 1.24
Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplant (2009) 1.24
Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum (2006) 1.20
Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leukoc Biol (1993) 1.15
Targeting the stromal microenvironment in chronic inflammation. Curr Opin Pharmacol (2006) 1.01
Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. Proc Natl Acad Sci U S A (2007) 1.01
Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display. Rheumatology (Oxford) (2004) 0.99
MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction? Ann Rheum Dis (2002) 0.97
Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol (1984) 0.94
Why does chronic inflammatory joint disease persist? Clin Med (2003) 0.93
What can we learn from epigenetics in the year 2009? Curr Opin Rheumatol (2010) 0.91
The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol (2000) 2.72
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) (2007) 1.97
Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol (1999) 1.87
Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis (2008) 1.86
Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol (2001) 1.66
Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum (2001) 1.59
The prevalence of patients with rheumatoid arthritis in the West Midlands fulfilling the BSR criteria for anti-tumour necrosis factor therapy: an out-patient study. Rheumatology (Oxford) (2003) 1.51
Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation (2000) 1.46
Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol (2007) 1.45
Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem (1997) 1.41
Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis. Rheumatology (Oxford) (2003) 1.18
Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin. Rheumatology (Oxford) (2008) 1.16
The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem (1999) 1.16
Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J Cell Sci (1999) 1.14
A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol (1997) 1.13
Analysis of the binding site on intercellular adhesion molecule 3 for the leukocyte integrin lymphocyte function-associated antigen 1. J Biol Chem (1995) 1.09
Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31. FEBS Lett (1999) 1.07
Smoke exposure as a determinant of autoantibody titre in α₁-antitrypsin deficiency and COPD. Eur Respir J (2010) 1.02
CD31 (PECAM-1) exists as a dimer and is heavily N-glycosylated. Biochem Biophys Res Commun (1999) 1.00
Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display. Rheumatology (Oxford) (2004) 0.99
Behavioural disturbance in people with Down's syndrome and dementia. J Intellect Disabil Res (1995) 0.97
Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Ann Rheum Dis (2004) 0.95
'I just thought it was normal aches and pains': a qualitative study of decision-making processes in patients with early rheumatoid arthritis. Rheumatology (Oxford) (2008) 0.95
Progression of imaging in pancreatitis panniculitis polyarthritis (PPP) syndrome. Scand J Rheumatol (2006) 0.94
Neutrophils sense flow-generated stress and direct their migration through alphaVbeta3-integrin. Am J Physiol (1999) 0.94
Why do we choose rheumatology? Implications for future recruitment--results of the 2006 UK Trainee Survey. Rheumatology (Oxford) (2008) 0.93
Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent. Rheumatology (Oxford) (2001) 0.90
Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss. Ann Rheum Dis (2009) 0.90
Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology (Oxford) (2008) 0.87
Characterization of four CD18 mutants in leucocyte adhesion deficient (LAD) patients with differential capacities to support expression and function of the CD11/CD18 integrins LFA-1, Mac-1 and p150,95. Clin Exp Immunol (2001) 0.85
The role of the cysteine-rich region of the beta2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Lett (1998) 0.83
A role for the integrin alpha6beta1 in the differential distribution of CD4 and CD8 T-cell subsets within the rheumatoid synovium. Rheumatology (Oxford) (2008) 0.81
Modulation of endothelial responses by the stromal microenvironment: effects on leucocyte recruitment. Biochem Soc Trans (2007) 0.79
Epitope mapping and functional properties of anti-intercellular adhesion molecule-3 (CD50) monoclonal antibodies. Eur J Immunol (1995) 0.79
Cell damage by viruses, toxins and complement: common features of pore-formation and its inhibition by Ca2+. Biochem Soc Symp (1985) 0.77
Anti-collagen type II antibodies in patients with very early synovitis. Ann Rheum Dis (2008) 0.77
Protection against complement-mediated cell damage by Ca2+ and Zn2+. Complement (1988) 0.77
Epidemiology of joint disorders in Parkinson's disease and their impact on health status. J Clin Neurosci (2009) 0.76
Type I interferons inhibit the resolution of chronic inflammation. Symp Soc Exp Biol (2000) 0.76
Methotrexate prescribing records: a primary and secondary care audit. Rheumatology (Oxford) (2003) 0.75
Skin cancer in psoriatic arthritis treated with anti-TNF therapy. Rheumatology (Oxford) (2007) 0.75
Case profile: unique uroradiographic manifestation of diverticulitis of colon. Urology (1982) 0.75